Diagnostic News and Research

RSS

Agfa HealthCare announces commercial launch of new Enterprise Content Management system

Agfa HealthCare announced today the commercial launch of a new version of its Enterprise Content Management (ECM) system featuring improved workflow capabilities that facilitate the capture, archiving, access and sharing of any type of documents outside of the Imaging scope across the hospital enterprise.

15 Apr 2015

Johns Hopkins researchers develop LevelCheck software to help improve surgical safety

Because the spine is made up of repeating elements that look alike, surgeons can mistakenly operate on the wrong vertebra. To avoid this, Johns Hopkins researchers have developed a software program that works seamlessly with currently available procedures to assist a surgeon’s determination of which vertebra is which. Results from its first clinical evaluation show that the LevelCheck software achieves 100 percent accuracy in just 26 seconds.

15 Apr 2015

BioLight Life Sciences announces first IOPtiMate™ system sale in Hungary

BioLight Life Sciences Investments Ltd., a firm that invests in, manages and commercializes biomedical innovations in ophthalmology and cancer diagnostics, today announced the first sale of the IOPtiMate™ system to a medical center located in Hungary.

14 Apr 2015

Capillary pCO2 helps determine IPAH diagnosis

Capillary pCO2 can be used to distinguish idiopathic pulmonary arterial hypertension from pulmonary hypertension due to heart failure with preserved ejection fraction, research indicates.

14 Apr 2015

Veracyte, GE parnter to develop new solutions to improve disease diagnosis

Veracyte, Inc., a molecular diagnostic company pioneering the field of molecular cytology, and GE today announced a research collaboration to develop new solutions that can improve disease diagnosis.

14 Apr 2015

Humabs BioMed reports clinical milestone in medImmune partnership

Humabs BioMed SA, a leading Swiss antibody therapeutics company, today announced that a novel antibody developed through its proprietary Cellclone technology will be investigated for the treatment of influenza A...

14 Apr 2015

Aeterna Zentaris plans to conduct Macrilen Phase 3 clinical study for AGHD

Aeterna Zentaris Inc. today announced plans to conduct a new, confirmatory Phase 3 clinical study to demonstrate the efficacy of Macrilen (macimorelin), a novel orally-active ghrelin agonist for use in evaluating adult growth hormone deficiency ("AGHD"), as well as a dedicated thorough QT study to evaluate the effect of Macrilen on myocardial repolarization.

13 Apr 2015

Simple, effective portable tool can help predict avian flu outbreaks

A simple and effective portable tool to predict avian flu outbreaks on farms has been created by University of Guelph researchers.

12 Apr 2015

Inova Diagnostics gains FDA de novo clearance for NOVA View automated digital IFA microscope

Inova Diagnostics, the worldwide leader in autoimmune diagnostic reagents and systems for the clinical laboratory, announced today that the United States Food and Drug Administration has cleared NOVA View, an automated digital IFA (indirect fluorescent assay) microscope, through the de novo classification process.

12 Apr 2015

VolitionRx adds three new laboratory automation systems to expedite sample analysis for its large ongoing clinical trials

Using its first installed robot, VolitionRx has recently completed the analysis of a first NuQ® assay on the complete set of 4,800 blood samples for its large retrospective, symptomatic population colorectal cancer study in collaboration with Hvidovre Hospital, University of Copenhagen, Denmark.

10 Apr 2015

TGen scientists discover the likely cause of rare type of muscle weakness in six children

Scientists at the Translational Genomics Research Institute (TGen), using state-of-the-art genetic technology, have discovered the likely cause of a child's rare type of severe muscle weakness.

10 Apr 2015

NIAID funds nine research projects to advance rapid diagnostics tests for drug-resistant bacteria

The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, has awarded more than $11 million in first-year funding for nine research projects supporting enhanced diagnostics to rapidly detect antimicrobial-resistant bacteria.

10 Apr 2015

fMRI can predict language development outcomes in ASD toddlers

Using functional magnetic resonance imaging (fMRI), University of California, San Diego School of Medicine researchers say it may be possible to predict future language development outcomes in toddlers with autistic spectrum disorder (ASD), even before they've been formally diagnosed with the condition.

10 Apr 2015

MammaPrint 70-gene breast cancer recurrence assay recommended in Germany’s AGO Guidelines

Agendia, a leading molecular diagnostics company that develops and markets genomic diagnostic products, announced at the St. Gallen International Breast Cancer Conference that new guidelines of the Arbeitsgemeinschaft Gynäkologische Onkologie (AGO) recommend the MammaPrint® 70-gene breast cancer recurrence assay in Germany’s 2015 guidelines for early-stage invasive breast cancer.

9 Apr 2015

Study suggests that pancreatic cancers harbor genetic alterations

A genetic analysis led by UT Southwestern Medical Center researchers suggests that most pancreatic cancers harbor genetic alterations that could be targeted by existing drugs, using their genetic features as a roadmap for treatment. The findings support a precision approach to treating pancreatic cancer, the fourth most deadly cancer for both men and women.

9 Apr 2015

New study describes economic consequences of using T2Candida Panel for detection of candidemia

A new study describes a model that estimates the economic consequences of using the T2Candida Panel (a novel diagnostic product that provides Candida detection) as an adjunct to the current blood culture-based diagnostic strategy in a high-risk hospital patient cohort.

9 Apr 2015

Stroke patients at greater risk of committing suicide compared with other population groups

Stroke patients can be up to twice as likely to commit suicide compared with the rest of the population, and the risk of attempted suicide is highest within the first two years after a stroke. These are the findings of a study from Umeå University published in the journal Neurology.

8 Apr 2015

Diagnostic News and Research

Agfa HealthCare announces commercial launch of new Enterprise Content Management system

Johns Hopkins researchers develop LevelCheck software to help improve surgical safety

BioLight Life Sciences announces first IOPtiMate™ system sale in Hungary

Capillary pCO2 helps determine IPAH diagnosis

Veracyte, GE parnter to develop new solutions to improve disease diagnosis

Humabs BioMed reports clinical milestone in medImmune partnership

Aeterna Zentaris plans to conduct Macrilen Phase 3 clinical study for AGHD

Simple, effective portable tool can help predict avian flu outbreaks

Inova Diagnostics gains FDA de novo clearance for NOVA View automated digital IFA microscope

VolitionRx adds three new laboratory automation systems to expedite sample analysis for its large ongoing clinical trials

TGen scientists discover the likely cause of rare type of muscle weakness in six children

NIAID funds nine research projects to advance rapid diagnostics tests for drug-resistant bacteria

fMRI can predict language development outcomes in ASD toddlers

MammaPrint 70-gene breast cancer recurrence assay recommended in Germany’s AGO Guidelines

Study suggests that pancreatic cancers harbor genetic alterations

New study describes economic consequences of using T2Candida Panel for detection of candidemia

Stroke patients at greater risk of committing suicide compared with other population groups

Not all psychopaths fit the 'cold, callous and untreatable' stereotype, shows study

Diagnostics Direct introduces CLIA approved diagnostic test, Syphilis Health Check

New study sheds light on linguistic characteristic of autistic children

Improving healthcare sustainability through carbon data

A New Approach to Preventing Bladder Cancer Recurrence

Bringing real-time analytics to downstream bioprocess monitoring

Latest News